Dex-IN
-
Recro Pharma Gains Russell Index Status
While some analysts thought Recro Pharma, Inc. of Malvern would face an uphill battle against pharmaceutical giants such as Johnson and Johnson, news continues to…
-
Recro Pharma Begins Clinical Trial Of Non-Opioid Dex-IN
Bunions hurt, and recovery from bunion surgery can take five months, but the Malvern specialty pharmaceutical company Recro Pharma announced they have just taken significant…
-
Recro Pharma Issues 1st Quarter Financials, Plans 2nd Quarter Clinical Trial
Recro Pharma, Inc., a Malvern-based specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, recently reported financial results for the first quarter ended…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
